![]() |
Jiangsu Transsimage Technology Co., Ltd. (002866.SZ) DCF -Bewertung
CN | Technology | Hardware, Equipment & Parts | SHZ
|

- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Jiangsu Transimage Technology Co., Ltd. (002866.SZ) Bundle
Entdecken Sie den finanziellen Ausblick von Jiangsu Transsimage Technology Co., Ltd. (002866SZ) mit unserem benutzerfreundlichen DCF-Taschenrechner! Geben Sie Ihre Projektionen für Wachstum, Margen und Ausgaben ein, um den inneren Wert der Jiangsu Transsimage Technology Co., Ltd. (002866SZ) zu berechnen, und verbessern Sie Ihre Anlagestrategie.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,533.9 | 1,769.8 | 1,920.5 | 1,998.7 | 1,773.5 | 1,847.6 | 1,924.7 | 2,005.0 | 2,088.7 | 2,175.9 |
Revenue Growth, % | 0 | 15.38 | 8.51 | 4.07 | -11.27 | 4.17 | 4.17 | 4.17 | 4.17 | 4.17 |
EBITDA | 129.0 | 218.5 | 256.6 | 210.1 | 146.1 | 195.4 | 203.5 | 212.0 | 220.9 | 230.1 |
EBITDA, % | 8.41 | 12.35 | 13.36 | 10.51 | 8.24 | 10.57 | 10.57 | 10.57 | 10.57 | 10.57 |
Depreciation | 40.0 | 45.5 | 64.4 | 80.8 | 106.3 | 68.6 | 71.5 | 74.5 | 77.6 | 80.8 |
Depreciation, % | 2.61 | 2.57 | 3.35 | 4.04 | 6 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 |
EBIT | 89.0 | 173.0 | 192.2 | 129.3 | 39.8 | 126.7 | 132.0 | 137.5 | 143.3 | 149.3 |
EBIT, % | 5.8 | 9.78 | 10.01 | 6.47 | 2.24 | 6.86 | 6.86 | 6.86 | 6.86 | 6.86 |
Total Cash | 194.1 | 699.2 | 746.3 | 571.2 | 622.4 | 571.6 | 595.5 | 620.3 | 646.2 | 673.2 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 553.6 | 703.3 | 647.3 | 597.8 | .0 | 515.3 | 536.8 | 559.2 | 582.5 | 606.8 |
Account Receivables, % | 36.09 | 39.74 | 33.71 | 29.91 | 0 | 27.89 | 27.89 | 27.89 | 27.89 | 27.89 |
Inventories | 264.2 | 348.5 | 379.3 | 301.1 | 445.9 | 358.0 | 372.9 | 388.5 | 404.7 | 421.6 |
Inventories, % | 17.22 | 19.69 | 19.75 | 15.07 | 25.14 | 19.37 | 19.37 | 19.37 | 19.37 | 19.37 |
Accounts Payable | 351.1 | 491.9 | 547.9 | 463.1 | 976.5 | 581.8 | 606.1 | 631.4 | 657.7 | 685.2 |
Accounts Payable, % | 22.89 | 27.8 | 28.53 | 23.17 | 55.06 | 31.49 | 31.49 | 31.49 | 31.49 | 31.49 |
Capital Expenditure | -95.9 | -160.1 | -405.2 | -548.0 | -619.5 | -364.9 | -380.1 | -396.0 | -412.5 | -429.7 |
Capital Expenditure, % | -6.26 | -9.05 | -21.1 | -27.42 | -34.93 | -19.75 | -19.75 | -19.75 | -19.75 | -19.75 |
Tax Rate, % | -741.1 | -741.1 | -741.1 | -741.1 | -741.1 | -741.1 | -741.1 | -741.1 | -741.1 | -741.1 |
EBITAT | 86.3 | 142.8 | 178.1 | 135.4 | 334.6 | 119.7 | 124.7 | 129.9 | 135.3 | 140.9 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -436.3 | -65.1 | -81.6 | -288.8 | 787.8 | -998.6 | -196.1 | -204.3 | -212.8 | -221.7 |
WACC, % | 5.46 | 5.36 | 5.43 | 5.48 | 5.48 | 5.44 | 5.44 | 5.44 | 5.44 | 5.44 |
PV UFCF | ||||||||||
SUM PV UFCF | -1,640.1 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | -231 | |||||||||
Terminal Value | -16,023 | |||||||||
Present Terminal Value | -12,295 | |||||||||
Enterprise Value | -13,935 | |||||||||
Net Debt | 327 | |||||||||
Equity Value | -14,262 | |||||||||
Diluted Shares Outstanding, MM | 298 | |||||||||
Equity Value Per Share | -47.83 |
What You Will Receive
- Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-filled financial data for Jiangsu Transimage Technology Co., Ltd. (002866SZ).
- Actual Data Insights: Historical performance metrics and projected estimates (highlighted in the yellow cells).
- Adjustable Forecasts: Modify key assumptions such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly assess how your inputs affect the valuation of Jiangsu Transimage Technology Co., Ltd. (002866SZ).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for ease of navigation and user-friendliness, complete with clear, step-by-step instructions.
Key Features
- Pre-Loaded Data: Historical financial statements and pre-filled forecasts for Jiangsu Transimage Technology Co., Ltd. (002866SZ).
- Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Instant Results: View recalculated intrinsic value for Jiangsu Transimage Technology Co., Ltd. (002866SZ) in real time.
- Clear Visual Outputs: Dashboard charts provide visualization of valuation outcomes and key metrics.
- Built for Accuracy: A reliable tool designed for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review the pre-filled data for Jiangsu Transimage Technology Co., Ltd. (002866SZ).
- Step 3: Modify the key assumptions (highlighted in yellow) according to your analysis.
- Step 4: Observe the automatic recalculations for Jiangsu Transimage Technology Co., Ltd.'s intrinsic value.
- Step 5: Utilize the results for investment decisions or reporting purposes.
Why Opt for This Calculator?
- Reliable Insights: Accurate financial data from Jiangsu Transimage Technology Co., Ltd. ensures trustworthy valuation outcomes.
- Flexible Customization: Modify essential factors such as growth projections, WACC, and tax rates to align with your forecasts.
- Efficiency Boost: Built-in calculations save you time by removing the hassle of starting from zero.
- Professional Standard: Tailored for investors, analysts, and consultants in the field.
- Easy to Use: A user-friendly design and clear, step-by-step guidance make it accessible for everyone.
Who Should Utilize This Product?
- Professional Investors: Develop comprehensive and dependable valuation models for portfolio assessments related to Jiangsu Transimage Technology Co., Ltd. (002866SZ).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Jiangsu Transimage Technology Co., Ltd. (002866SZ).
- Students and Educators: Leverage real-world data to enhance skills in financial modeling and teaching.
- Tech Enthusiasts: Gain a deeper understanding of how technology firms like Jiangsu Transimage Technology Co., Ltd. (002866SZ) are appraised in the market.
Contents of the Template
- Preloaded JTTC Data: Historical and projected financial metrics, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade spreadsheets designed for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for customizing revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financial reports for in-depth analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios for assessing performance.
- Dashboard and Charts: Visual representations of valuation results and underlying assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.